L Beishon1, J S Minhas1,2, R Nogueira3, P Castro4, C Budgeon2, M Aries5, S Payne6, T G Robinson1,2, R B Panerai1,2. 1. CHIASM Group, Department of Cardiovascular Sciences, University of Leicester, Leicester, UK. 2. NIHR Leicester Biomedical Research Centre, British Heart Foundation Cardiovascular Research Centre, Glenfield Hospital, Leicester, UK. 3. Neurology Department, School of Medicine, Hospital das Clinicas, University of São Paulo, São Paulo, Post Brazil. 4. Stroke Unit and Department of Neurology, Centro Hospitalar Universitário São João, Porto, Portugal. 5. Department of Intensive Care, University Maastricht, Maastricht University Medical Center, Maastricht, Netherlands. 6. Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK.
Abstract
RATIONALE: Disturbances in dynamic cerebral autoregulation after ischemic stroke may have important implications for prognosis. Recent meta-analyses have been hampered by heterogeneity and small samples. AIM AND/OR HYPOTHESIS: The aim of study is to undertake an individual patient data meta-analysis (IPD-MA) of dynamic cerebral autoregulation changes post-ischemic stroke and to determine a predictive model for outcome in ischemic stroke using information combined from dynamic cerebral autoregulation, clinical history, and neuroimaging. SAMPLE SIZE ESTIMATES: To detect a change of 2% between categories in modified Rankin scale requires a sample size of ∼1500 patients with moderate to severe stroke, and a change of 1 in autoregulation index requires a sample size of 45 healthy individuals (powered at 80%, α = 0.05). Pooled estimates of mean and standard deviation derived from this study will be used to inform sample size calculations for adequately powered future dynamic cerebral autoregulation studies in ischemic stroke. METHODS AND DESIGN: This is an IPD-MA as part of an international, multi-center collaboration (INFOMATAS) with three phases. Firstly, univariate analyses will be constructed for primary (modified Rankin scale) and secondary outcomes, with key co-variates and dynamic cerebral autoregulation parameters. Participants clustering from within studies will be accounted for with random effects. Secondly, dynamic cerebral autoregulation variables will be validated for diagnostic and prognostic accuracy in ischemic stroke using summary receiver operating characteristic curve analysis. Finally, the prognostic accuracy will be determined for four different models combining clinical history, neuroimaging, and dynamic cerebral autoregulation parameters. STUDY OUTCOME(S): The outcomes for this study are to determine the relationship between clinical outcome, dynamic cerebral autoregulation changes, and baseline patient demographics, to determine the diagnostic and prognostic accuracy of dynamic cerebral autoregulation parameters, and to develop a prognostic model using dynamic cerebral autoregulation in ischemic stroke. DISCUSSION: This is the first international collaboration to use IPD-MA to determine prognostic models of dynamic cerebral autoregulation for patients with ischemic stroke.
RATIONALE: Disturbances in dynamic cerebral autoregulation after ischemic stroke may have important implications for prognosis. Recent meta-analyses have been hampered by heterogeneity and small samples. AIM AND/OR HYPOTHESIS: The aim of study is to undertake an individual patient data meta-analysis (IPD-MA) of dynamic cerebral autoregulation changes post-ischemic stroke and to determine a predictive model for outcome in ischemic stroke using information combined from dynamic cerebral autoregulation, clinical history, and neuroimaging. SAMPLE SIZE ESTIMATES: To detect a change of 2% between categories in modified Rankin scale requires a sample size of ∼1500 patients with moderate to severe stroke, and a change of 1 in autoregulation index requires a sample size of 45 healthy individuals (powered at 80%, α = 0.05). Pooled estimates of mean and standard deviation derived from this study will be used to inform sample size calculations for adequately powered future dynamic cerebral autoregulation studies in ischemic stroke. METHODS AND DESIGN: This is an IPD-MA as part of an international, multi-center collaboration (INFOMATAS) with three phases. Firstly, univariate analyses will be constructed for primary (modified Rankin scale) and secondary outcomes, with key co-variates and dynamic cerebral autoregulation parameters. Participants clustering from within studies will be accounted for with random effects. Secondly, dynamic cerebral autoregulation variables will be validated for diagnostic and prognostic accuracy in ischemic stroke using summary receiver operating characteristic curve analysis. Finally, the prognostic accuracy will be determined for four different models combining clinical history, neuroimaging, and dynamic cerebral autoregulation parameters. STUDY OUTCOME(S): The outcomes for this study are to determine the relationship between clinical outcome, dynamic cerebral autoregulation changes, and baseline patient demographics, to determine the diagnostic and prognostic accuracy of dynamic cerebral autoregulation parameters, and to develop a prognostic model using dynamic cerebral autoregulation in ischemic stroke. DISCUSSION: This is the first international collaboration to use IPD-MA to determine prognostic models of dynamic cerebral autoregulation for patients with ischemic stroke.
Authors: Marcel J H Aries; Jan W Elting; Jacques De Keyser; Berry P H Kremer; Patrick C A J Vroomen Journal: Stroke Date: 2010-10-07 Impact factor: 7.914
Authors: Jurgen A H R Claassen; Aisha S S Meel-van den Abeelen; David M Simpson; Ronney B Panerai Journal: J Cereb Blood Flow Metab Date: 2016-01-18 Impact factor: 6.200
Authors: Lesley A Stewart; Mike Clarke; Maroeska Rovers; Richard D Riley; Mark Simmonds; Gavin Stewart; Jayne F Tierney Journal: JAMA Date: 2015-04-28 Impact factor: 56.272
Authors: Angela Sm Salinet; Nathália Cc Silva; Juliana Caldas; Daniel S de Azevedo; Marcelo de-Lima-Oliveira; Ricardo C Nogueira; Adriana B Conforto; Manoel J Texeira; Thompson G Robinson; Ronney B Panerai; Edson Bor-Seng-Shu Journal: J Cereb Blood Flow Metab Date: 2018-08-17 Impact factor: 6.200
Authors: Marit L Sanders; Jan Willem J Elting; Ronney B Panerai; Marcel Aries; Edson Bor-Seng-Shu; Alexander Caicedo; Max Chacon; Erik D Gommer; Sabine Van Huffel; José L Jara; Kyriaki Kostoglou; Adam Mahdi; Vasilis Z Marmarelis; Georgios D Mitsis; Martin Müller; Dragana Nikolic; Ricardo C Nogueira; Stephen J Payne; Corina Puppo; Dae C Shin; David M Simpson; Takashi Tarumi; Bernardo Yelicich; Rong Zhang; Jurgen A H R Claassen Journal: Front Physiol Date: 2019-07-09 Impact factor: 4.566
Authors: Ricardo C Nogueira; Marcel Aries; Jatinder S Minhas; Nils H Petersen; Li Xiong; Jana M Kainerstorfer; Pedro Castro Journal: J Cereb Blood Flow Metab Date: 2021-09-13 Impact factor: 6.960